China’s NMPA authorises Santen’s glaucoma treatment application
Glaucoma damages the optic nerve and results in visual field loss.
Drug Manufacturers
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
Radiopharmaceutical deals drive sector growth despite supply crisis
Purdue and Sackler family agree to $7.4bn national opioid settlement
FDA review designations: tracking 40 years of innovation
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy
